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Sa´ndor Me´sza´rosb, and Janos MinarovitsbPurpose of review
We wished to overview recent data on a subset of epigenetic changes elicited by intracellular bacteria in
human cells. Reprogramming the gene expression pattern of various host cells may facilitate bacterial
growth, survival, and spread.
Recent findings
DNA-(cytosine C5)-methyltransferases of Mycoplasma hyorhinis targeting cytosine-phosphate-guanine
(CpG) dinucleotides and a Mycobacterium tuberculosis methyltransferase targeting non-CpG sites
methylated the host cell DNA and altered the pattern of gene expression. Gene silencing by CpG
methylation and histone deacetylation, mediated by cellular enzymes, also occurred in M. tuberculosis-
infected macrophages. M. tuberculosis elicited cell type-specific epigenetic changes: it caused increased
DNA methylation in macrophages, but induced demethylation, deposition of euchromatic histone marks
and activation of immune-related genes in dendritic cells. A secreted transposase of Acinetobacter
baumannii silenced a cellular gene, whereas Mycobacterium leprae altered the epigenotype, phenotype,
and fate of infected Schwann cells. The ‘keystone pathogen’ oral bacterium Porphyromonas gingivalis
induced local DNA methylation and increased the level of histone acetylation in host cells. These
epigenetic changes at the biofilm–gingiva interface may contribute to the development of periodontitis.
Summary
Epigenetic regulators produced by intracellular bacteria alter the epigenotype and gene expression pattern
of host cells and play an important role in pathogenesis.
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Extracellular bacteria grow outside the cells of the
infected host, whereas obligate intracellular bacteria
enter into cells and use host cell resources for their
replication [1]. Furthermore, a growing number of
facultative intracellular bacteria can multiply both
inside and outside host cells [2]. In addition to
structural virulence factors, bacterial effector
proteins that interact with the host may also facili-
tate disease initiation and progression [3,4,5
&&
]. The
transport of effectors from the bacterial cytosol into
the host cells is typically mediated by translocation
complexes called type III, type IV, and type VII
secretion systems [6
&
–9
&
,10].
After entering the host cell, bacterial effector
proteins may undergo covalent modification by
cellular enzymes and their interaction with their
targets may affect key processes of cellular physi-
ology [4,5
&&
]. Various bacterial effectors are located
to discrete cellular compartments [5
&&
]. A set of
effector proteins is translocated to the nucleus
and interacts with the chromatin [11,12
&
]. Suchrs Kluwer Health, Inc. All rights rese
 Kluwer Health, Inc. Unaeffectors, some of them called nucleomodulins,
may alter the cellular epigenotype and gene expres-
sion pattern [13,14,15
&
,16
&&
,17].
Although it is well documented that intracellu-
lar bacteria, including Campylobacter rectus, uropa-
thogenic Escherichia coli, and Helicobacter pylori
silence host genes by the induction of DNA hyper-
methylation, the exact mechanisms mediating epi-
genetic dysregulation by these pathogens has not
been clarified [18,19]. Recent studies, however, elu-
cidated the mechanism of de novo methylation inrved. www.co-infectiousdiseases.com
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KEY POINTS
 Bacterial DNMTs target the host cell DNA and alter the
host cell methylome.
 Intracellular bacteria may possess an array of
epigenetic regulators that target the cellular
epigenetic machinery.
 The epigenetic alterations elicited by the same bacterial
pathogen depend on the host cell phenotype.
 Epigenetic regulators produced by intracellular bacteria
may facilitate bacterial growth, survival, and spread.
 The epigenetic changes induced by intracellular
bacteria may serve as diagnostic tools and as targets
of epigenetic therapy.
Pathogenesis and immune response
Copcells infected by Mycoplasma hyorhinis and Mycobac-
terium tuberculosis [20
&&
,21,22,23
&&
].Epigenetic reprogramming of host cells by
Mycoplasma hyorhinis DNA
methyltransferases
Although Mycoplasma was considered as extracellu-
lar bacteria, their reduced genome may reflect a
strictly parasitic lifestyle [24
&
]. Mycoplasma species
either adhere to host cells or invade cells and rep-
licate intracellularly for prolonged periods [25
&
,26
&
].
Mycoplasma salivariumwas detected in the epithelial
cells of oral leukoplakia, a premalignant condition
of the oral cavity, whereasMycoplasma hominis infec-
tion was associated with prostate cancer [27,28
&
].
SeveralMycoplasma species includingM.hyorhinis,
encode DNA-(cytosine-5)-methyltransferase (DNMT)
enzymes that target cytosine-phosphate-guanine
(CpG) dinucleotides, similarly to their mammalian
counterparts [20
&&
,29,30]. These enzymes establish
the methylation patterns of the bacterial genomes.
When expressed in human cells, they are also capable
to translocate into the cell nucleus and create aberrant
methylation patterns of the host cell DNA [20
&&
,21].
Chernov et al. [21] demonstrated that expression
ofMhy1, aM.hyorhinis gene coding for aCpG-specific
bacterial DNMT caused genome-wide methylation
changes of the host DNA in transfected human fibro-
sarcoma and trophoblast cells. In parallel, the expres-
sion of certain cellular genes was upregulated,
whereas another gene set showed a decreased level
of transcription. All of these changes resulted in
the activation of proliferation-specific pathways. A
dual-specific DNMT encoded by Mhy2 was also
active in human cells, it methylated both CpG dinu-
cleotides and cytosines in a non-CpG sequence [21].2 www.co-infectiousdiseases.com
yright © 2017 Wolters Kluwer Health, Inc. UnautA subset of CpG dinucleotides was also modified in
humancells byMhy3, aM.hyorhinismethylase target-
ing GATC sequences [21]. ‘Reprogramming’ of the
host epigenome byMycoplasma species may contrib-
ute to the initiation or progression of malignant
tumours [21,31
&
,32].Alteration of the host cell epigenotype by
Mycobacterium tuberculosis: noncanonical
and classical epigenetic mechanisms
M. tuberculosis, the causative agent of tuberculosis,
infects humans by the respiratory route. Although
the bacterium is engulfed by alveolar macrophages,
its survival strategies, such as the inhibition of phag-
osome–lysosome fusion, allow intracellular persist-
ence and replication [33,34
&
,35
&
]. Sharma et al. [22]
observed thatRv2966c, a secretedprotein encodedby
the genome of M. tuberculosis could enter human
monocytic cell line derived from an acutemonocytic
leukemia patient (THP1) cells. Following nuclear
transport, Rv2966c methylated the host cell DNA
at cytosines located outside CpG dinucleotides, typ-
ically at cytosine-phosphate-adenine and cytosine-
phosphate-thymine sites [22]. Methylation at non-
CpG sites occurs in stem cells and neoplastic cells in
mammals, but it is usually absent from adult differ-
entiated cell types, with few exceptions [36].
Sharma et al. [22] argued that non-CpG meth-
ylation could persist for a prolonged period in the
genome of M. tuberculosis infected, nondividing
macrophages. Non-CpGmethylation in the intronic
region of the histone variant gene H2AFY2 and in
the GRK5 gene encoding a G protein-coupled recep-
tor kinase caused transcriptional repression.
Rv2966c could bind to specific DNA sequences
and interacted with the activating chromatin
marks H3K4me3 and H3K36me3 (histone H3 trime-
thylated at lysine 4 and 36, respectively) [22]. In a
follow-up study, Sharma et al. [23
&&
] observed
genome-wide de novo methylation at non-CpG
dinucleotides in THP1 macrophages infected with
M. tuberculosis strain H37Rv. In addition to hyper-
methylated regions, hypomethylated regions were
also detected. Differentially methylated regions,
especially hypermethylated sequences, frequently
carried a 28 base pair motif with a conserved
‘GCCTCC’ core sequence [23
&&
]. TheH37Rv-induced
changes in the host cell epigenome and transcrip-
tome may establish a favourable environment for
the intracellular persistence of the bacterium.
Infection of THP-1-derived macrophages with
clinical isolates of M. tuberculosis-induced hyperme-
thylation at CpG dinucleotides in promoter sequen-
ces of several interleukin receptor genes, including
the promoter for interleukin 6 receptor [37
&
]. ThisVolume 30  Number 00  Month 2017
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Cepigenetic change may downregulate the level of
interleukin 6 receptor protein mediating the effects
of the pleiotropic regulator interleukin 6.
In addition to an unusual non-CpG DNA meth-
ylase, the genome of M. tuberculosis encodes an
‘unorthodox’ protein arginine methyltransferase,
too. Unlike its eukaryotic counterparts that target
the long N-terminal tail of histones, the bacterial
enzyme Rv1988 dimethylated an arginine residue
located to the core region of histoneH3 [38]. Rv1988
repressed a series of host defence genes coding for
enzymes generating reactive oxygen species and
nitric oxide. The expression of tumour necrosis
factor receptor-associated factor 3, coding for an
ubiquitin ligase of the tumour necrosis factor recep-
tor-associated factor family, was also suppressed
[38]. Thus, a bacterial histone arginine methyltrans-
ferase may block host defences, possibly promoting
thereby pathogen survival.
A classical epigenetic mechanism, promoter
silencing by the upregulation of the cellular histone
deacetylase 1, was also observed in M. tuberculosis-
infected macrophages [39]. Silencing of the inter-
leukin-12b promoter was accompanied by the
recruitment of HDAC1 and histone H3 deacetyla-
tion. Thus, M. tuberculosis may suppress the expres-
sion of a key regulator of the T helper 1 response by
epigenetic modification [39].
M. tuberculosis may also elicit, however, histone
acetylation, because Rv3423.1, a bacterial histone
acetyltransferase could be detected in the chromatin
of infected macrophages [40
&
]. Rv3423.1 generated
euchromatic histone marks by acetylating histone
H3 at lysine K9 and K14.
In contrast to THP-1-derived macrophages,
humanmonocyte-derived dendritic cells permit only
a constrained intracellular survival for M. tuberculosis
[41].Thecellular epigenome inM. tuberculosis-infected
dendritic cells was characterized by demethylation at
distal enhancer elements and an increased level ofTable 1. Mycobacterium tuberculosis induced epigenetic alteratio
Effector Function
Rv2966c DNA-(cytosine-5)-methyltransferase targeting CpA
and CpT
ND Induction of DNA methylation at CpG dinucleotides
Rv1988 Protein arginine methyltransferase dimethylating
histone H3 arginine 42 (H3R42)
ND Upregulation of HDAC1 (cellular histone
deacetylase)
Rv3423.1 Bacterial histone acetyltransferase
ND Induction of DNA demethylation and deposition of
euchromatic histone marks
CpA, cytosine-phosphate-adenine; CpG, cytosine-phosphate-guanine; CpT, cytosine
0951-7375 Copyright  2017 Wolters Kluwer Health, Inc. All rights rese
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activation of the immune-related genes REL, CD83,
and NFKB1 occurred before DNA demethylation [42].
Thus, the epigenetic alterations induced by M. tuber-
culosis are cell type specific, that is, they differ in
macrophages and dendritic cells (Table 1).
Identification of epigenetic ‘signatures’ in gra-
nulocytes and monocytes of patients with active
tuberculosis and latent M. tuberculosis infection
may help to monitor the development and pro-
gressionof tuberculosis [43]. Because epigeneticproc-
esses are reversible, microbe-induced epigenetic
alterations arepotential targets of epigenetic therapy.Induction of promoter hypermethylation in
host cells by an Acinetobacter baumannii
transposase
The genome of Acinetobacter baumannii, a nonoral
facultative intracellular bacterium involved in noso-
comial infections and periodontitis, encodes a trans-
posase protein that is associated with secreted outer
membrane vesicles (OMVs) [44,45]. After delivery
via OMVs to host cells, the transposase translocates
to the nucleus and acts as a bacterial effector by
inducing hypermethylation and silencing of the
cellular E-cadherin promoter [45]. Thus, A. bauman-
nii may induce epigenetic alterations and downre-
gulation of the tumour suppressor protein E-
cadherin in uninfected host cells that take upOMVs.
Further studies may reveal the exact mechanism of
transposase-mediated CpG methylation.Epigenetic reprogramming of host cells by
Mycobacterium leprae, an obligate
intracellular bacterium
Intracellular bacteria including Helicobacter pylori,
Lactobacillus acidophilus, and Mycobacterium leprae
may alter the phenotype and fate of somatic cellsns in host cells: recent advances
Effect Reference
Gene silencing in macrophages [22,23&&]
Gene silencing (?) in macrophages [37&]
Gene silencing in macrophages [38]
Gene silencing in macrophages [39]
Gene activation (?) in macrophages [40&]
Gene activation in dendritic cells [42]
-phosphate-thymine; HDAC1, histone deacetylase; ND, not determined.
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Cop[46]. In an experimentalmodel of human leprosy,M.
leprae infection of mouse primary Schwann cells
caused downregulation of the master regulator Sry-
relatedHMG(highmobilitygroup)box10 inhost cell
nuclei, possiblybecauseofbacterium-induced,meth-
ylation-mediated silencing of the Sox10 gene [47]. In
parallel, the transcription of the Sox10-regulated
myelin genes decreased, whereas a series of genes
involved in epithelial–mesenchymal transition
(EMT) were demethylated and activated. Thus, the
M. leprae-infected Schwann cells acquired the pheno-
type of progenitor/stem-like cells. Accordingly, they
could differentiate into myofibers and smooth
muscles both in vitro and in vivo, a phenomenon that
may facilitate the dissemination of bacteria [47,48].
The exact mechanism of M. leprae-induced
reprogramming remains to be elucidated. We
suggest that EMT was initiated by the virulence
factor phenolic glycolipid (PGL) which is loosely
linked to the outer cell wall layer of the bacterium.
PGL can modulate macrophage function by reduc-
ing the levels of inflammatory mediators (tumor
necrosis factor-a, interleukin 6, and interleukin-
1b) released from the activated cells [49
&
]. Other
candidates for the induction of EMT are the putative
ligands binding to Toll-like receptor 4 (TLR4) [50
&
].
These molecules comprise lipooligosacharides, pro-
line–glutamate/proline–proline–glutamate
proteins that are abundant in pathogenic mycobac-
teria, and putativeM. leprae orthologs of TLR4-bind-
ing proteins characterized in M. tuberculosis [50
&
].
The function of a number of proteins encoded by
the M. leprae genome is unknown at present [51].
Their characterization may reveal further important
aspects of M. leprae–host cell interactions.Epigenetic alterations induced by oral
bacteria
Polymicrobial communities of oral bacteria regu-
larly form biofilms on surfaces within the mouth
[52
&&
]. Dental plaques, the biofilms located to the
tooth surface play a crucial role in the development
of such highly prevalent oral diseases as caries,
gingivitis, and periodontitis [53]. Oral bacteria were
implicated in the pathogenesis of oral carcinoma,
too [54
&
,55
&
]. Moreover, it was suggested that Por-
phyromonas gingivalis, the ‘keystone pathogen’ of
periodontitis and Fusobacterium nucleatum promote
colorectal carcinogenesis [56
&
].
P. gingivalis, a low-abundance biofilm species is
capable to trigger an inflammatory response and
impair, in parallel, various host defence mechan-
isms [53,57
&
,58
&
]. These changes allow enhanced
replication of other bacteria located to the dental
biofilm. The relative abundance of individual4 www.co-infectiousdiseases.com
yright © 2017 Wolters Kluwer Health, Inc. Unautmembers of the bacterial community is also altered,
resulting in periodontitis, a dysbiotic disease. Perio-
dontitis is characterized by complement activation,
tissue destruction, increased efflux of gingival crev-
icular fluid, periodontal pocket formation, and
alveolar bone loss [59,60
&
]. P. gingivalis excerts a
disproportionately large effect on the structure of
the microbial community resulting in the transition
of a ‘healthy’ plaque into a ‘pathological’ plaque
[53,59]. This keystone pathogen coaggregates with
other bacteria and alters the gene expression pattern
of the microbial community [61,62,63
&
,64
&
].
In addition to interactingwithbacteria located to
thedentalplaque,P. gingivalis alsoadheres togingival
epithelial cells (GECs) and persists and multiplies
intracellularly [65,66
&
]. After internalization into
early phagosomes the bacterium is protected from
immune mechanisms, and by the activation of cel-
lular autophagy, it getsaccess tohostproteins that are
utilizedas sourcesof carbonandnitrogen.P. gingivalis
is able to exit the host cell and reenter into neigh-
bouring cells [66
&
]. A recent study demonstrated that
a prolonged interaction with P. gingivalis increased
the methylation of the TLR2 promoter in GECs [67].
Using a reporter construct, the activity of the meth-
ylated TLR2 promoter was reduced compared with
the unmethylated one. Because TLR2 is involved
in the recognition of the pathogen and it is indis-
pensable for the upregulation of cytokine and anti-
microbial peptide production following bacterial
stimulation, methylation-mediated inhibition of
TLR2 expression may result in innate immune dys-
biosis manifested as hyporesponsibility of the GECs
to P. gingivalis [67].
Short-term interactionof lipopolysacharide (LPS)
derived from P. gingivalis with human oral keratino-
cytes also induced epigenetic alterations. Martins
et al. [68] found that the level of acetylated histone
H3, a euchromatic mark associated with active pro-
moters, increased quickly following LPS exposure.
Coinfection by P. gingivalis and Filifactor alocis, a
Gram-positive anaerobic rod associated with perio-
dontitis, downregulated the level of histone H1
family members in epithelial cells [69,70]. This
may alter the structure of nucleosome and the host
cell transcriptome.
In addition to P. gingivalis-derived LPS, short-
chain fatty acids (SCFAs) secreted by the bacterium
may also increase histone acetylation and activate
promoters in host cells. Furthermore, SCFAs inhibit
histone deacetylase enzymes that remove acetylmoi-
eties fromhistone tails, and suppresshistoneN-lysine
methyltransferases that create heterochromatic
marks at inactive promoters. SCFAs produced by P.
gingivalis and Fusobacterium nucleatum reactivated
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Cthey switched on the lytic (productive) replication
cycle of Kaposi’s sarcoma-associated herpesvirus and
Epstein–Barr virus (EBV) [71,72]. In HIV- infected
individuals activation of Kaposi’s sarcoma-associated
herpesvirus replication may contribute to the devel-
opment of oral Kaposi’s sarcoma, whereas EBV infec-
tion was associated with chronic periodontitis and
with the presence of P. gingivalis in Japanese patients
[73]. In pregnant women, coinfection of EBV and P.
gingivalis may also facilitate the development of
chronic periodontitis [74].
Thus, bacterium–host cell interactions may
contribute to the epigenetic reprogramming of
host cells at the biofilm–gingiva interface [71].
The altered host cell epigenotype and gene expres-
sion pattern as well as viral coinfections amplified
by epigenetic regulators of bacterial origin may
play a role in the progression of periodontitis
[71,72].Mobilization of chromosomally integrated
human herpesvirus 6 genome by Chlamydia
trachomatis
The termini of the linear viral genomes of human
herpesvirus (HHV) 6 and HHV7 consist of repetitive
sequences, similarly to the human telomeric hexa-
nucleotide TTAGGG. Both HHV6 and, HHV7 can
integrate to subtelomeric chromosomal regions and
have the ability to enter the human germline [75
&
].
About 0.5% of the population carries silent, chro-
mosomally integrated HHV6 genomes that are
transmitted vertically in a Mendelian fashion.
Under specific conditions, such as pregnancy or
immune suppression, chromosomally integrated
HHV6 genomes may be reactivated and become
infectious again, causing disease [76,77].
Chlamydia trachomatis, an obligate intracellular
Gram-negative bacterium, causes inflammatory dis-
eases. It uses the ephrin receptor tyrosine kinase A2
as a receptor for cellular entry [78]. Strangely
enough, this receptor is also used by hepatitis C
virus and HHV8 [79,80]. A nuclear effector protein
secreted by C. trachomatis has histone methyl-trans-
ferase activity targeting histones H2B, H3, and
H4 (reviewed in [81]). Because C. trachomatis is
sexually transmitted and is able to interfere with
DNA damage response and telomeric damage
response signalling, it was implicated in ovarian
carcinogenesis [82]. In vitro, C. trachomatis super-
infection is able to mobilize silenced chromoso-
mally integrated HHV6 genomes from their
subtelomeric locations via telomeric circle for-
mation [83]. The unexpected interplay between C.
trachomatis and HHV6 may be of great importance
and warrants further experiments.0951-7375 Copyright  2017 Wolters Kluwer Health, Inc. All rights rese
opyright © 2017 Wolters Kluwer Health, Inc. UnaCONCLUSION
A diverse set of intracellular bacteria causes epige-
netic dysregulation in host cells that contributes to
disease initiation and progression.
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